https://scholars.lib.ntu.edu.tw/handle/123456789/480971
標題: | New options for pneumothorax management | 作者: | KE-CHENG CHEN PEI-HSING CHEN JIN-SHING CHEN |
關鍵字: | novel Treatments; pleurodesis; Primary Spontaneous Pneumothorax | 公開日期: | 2020 | 出版社: | Taylor and Francis Ltd | 來源出版物: | Expert Review of Respiratory Medicine | 摘要: | Introduction: Pneumothorax is defined as the presence of air in the pleural space. Spontaneous pneumothorax, occurring without antecedent traumatic or iatrogenic cause, is classified as primary or secondary. There are substantial inconsistencies in international guidelines for the treatment of pneumothorax. Moreover, many geographical variations exist in daily clinical practice. Areas covered: In this article, we focus on novel treatment modalities for this significant health problem in young adults. Expert opinion: In part, these discrepancies have been caused by the lack of high-quality trials or evidence. Currently, the pathophysiological mechanisms underlying pneumothorax are better understood and have implications for clinical management. Studies have demonstrated that the judicious use of pleurodesis can decrease its rate of recurrence, both in surgical and nonsurgical patients. ? 2020, ? 2020 Informa UK Limited, trading as Taylor & Francis Group. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081748521&doi=10.1080%2f17476348.2020.1740090&partnerID=40&md5=67b42d2261a0363144d74ebf39021f61 https://scholars.lib.ntu.edu.tw/handle/123456789/480971 |
ISSN: | 1747-6348 | DOI: | 10.1080/17476348.2020.1740090 | SDG/關鍵字: | bleomycin; minocycline; picibanil; povidone iodine; talc; tetracycline; blood patch; disease classification; human; pleurodesis; pneumothorax; recurrent disease; Review; treatment planning; disease management; pneumothorax; young adult; Disease Management; Humans; Pleurodesis; Pneumothorax; Recurrence; Young Adult |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。